Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

Valued at a market cap of almost $87.4 billion, Altria Group, Inc. (MO) manufactures and sells smokeable and oral tobacco ...

Why did Swedish nicotine pouches become the go-to fix for blasting through long working days and longer nights out?

On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.

Are non-cigarette tobacco products bad for your heart? KYW medical editor Dr. Brian McDonough looks at a report based on seven decades of research.

Snus, the smokeless tobacco product with Scandinavian origins, has gained popularity among celebrities, particularly athletes and entertainers. With its discreet nature and reduced health risks ...

The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...

Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...

Deutsche Bank analyst Damian McNeela maintained a Buy rating on British American Tobacco (BATS – Research Report) today and set a price target ...

UBS Group upgraded shares of British American Tobacco (NYSE:BTI – Free Report) from a neutral rating to a buy rating in a research report report published on Monday morning, Marketbeat.com reports.

The-Montgomery County Industrial Development Board and the Area Chamber of Commerce are highlighting our century-old ...